Overview


The US blood cell washer kit market is estimated to grow 1.7x between 2024 and 2032, creating an absolute opportunity of more than US$12.5 million during the forecast period. The growth of the market is being driven by a rising demand for automated blood processing systems within hospitals and research laboratories. The increasing adoption of advanced hematology technologies, coupled with the necessity for effective separation of blood components, is contributing to this market expansion. Additionally, ongoing innovations in cell washing kits are not only enhancing patient safety but also improving workflow efficiency, positioning this sector as a highly promising segment within the US healthcare technology landscape. Washed red blood cells had the majority of their plasma, platelets, and white blood cells removed and replaced with saline or another type of preservation solution. The most prevalent rationale for employing cleansed red blood cells in transfusion therapy is to avoid recurring severe allergic transfusion responses that do not respond to medical treatment. Proteins in donor plasma are commonly responsible for severe allergic responses. These proteins are eliminated during the washing process of red blood cells.

Technological Advancements

Automation and Integration: There is an increasing trend toward automation in blood cell washing systems, resulting in improved efficiency and consistency in laboratory processes.

Advanced Features: Modern cell washers now feature real-time monitoring, intuitive interfaces, and improved safety protocols to enhance usability and reliability.

In the fascinating world of blood transfusions, washed red blood cells take center stage! These special cells undergo a meticulous process where most of their plasma, platelets, and white blood cells are carefully stripped away, then replaced with saline or a proprietary preservation solution.  Why go through this effort, you might wonder? The primary reason is to prevent those dreaded, severe allergic reactions that some patients experience during transfusions, reactions that can be tough to treat with standard medical interventions. The culprits behind these allergies are often proteins found in donor plasma, which are effectively eliminated in the washing process. By using cleansed red blood cells, medical professionals can ensure a safer and more comfortable transfusion experience for their patients.

Increasing R&D investments and research grants; increasing prevalence of infectious diseases leading to a higher volume of sample testing & cell-based research in laboratory centrifuges, are certain factors augmenting the market growth across the globe.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Blood Cell Washers Kits Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share, and regional proliferation of this business. Moreover, the report offers insights into the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Blood Cell Washers Kits Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry, and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific
  • Andreas Hettich GmbH & Co.KG
  • Bio-Rad Laboratories, Inc
  • Labtron
  • Molecular Devices
  • Biotechnology Medical Services K. Group
  • Helmer Scientific
  • Beckman Coulter, Inc.
  • Sino Pharmaceutical Equipment Limited Co. Ltd
  • Labnics Equipments ltd
  • GMI Inc.

(Note: The list of major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Blood Cell Washers Kits Market:

Thermo Fisher Scientific

  • In November 2024, the CW3 Cell Washer was unveiled as an FDA-cleared automated system designed to process up to 24 tubes in approximately 3 minutes. This system offers improved reproducibility, reduced plasma carry-over, and spill-over prevention. Additionally, it features enhanced user safety measures, including decant speed control and saline-level alerts to minimize the risk of cross-contamination.
  • The CW3 Cell Washer could wash up to 24 samples in just 3 minutes. It provided fully automatic and manual modes, featuring customizable decanting speeds to ensure optimal corpuscle dryness.

Bio-Rad Laboratories, Inc

  • Introduces the DiaCent-CW Cell Wash Centrifuge, designed for traditional tube-based blood washing in typing and antibody screening processes.
  • Offers innovative accessories and consumables, such as the Leucoperm kit for cell fixation before flow cytometry, which enhances preparation flexibility.

Labtron

  • Product Overview: The LCW-A10 is a high-performance cell washing centrifuge that efficiently separates and washes cells at 4000 rpm. It features advanced controls for adjusting speed and duration, customizable wash cycles, and an integrated data logging system.
  • Product Line: Labtron also provides the LCW-A20 model, which offers similar features but with a higher capacity for larger sample volumes.
     

By Washer Type

  • Micro Washers
  • Bench-top Washers
  • Standalone Washers

By Modality

  • Manual
  • Semi-Automated
  • Fully Automated

By End Users

  • Hospital based Laboratories
  • Academic and Research Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Here’s a regional view of where the most progress is happening 

North America

  • North America is currently the dominant region in the Blood Cell Washer Kits Market, primarily due to its advanced healthcare infrastructure, strong research and development initiatives, supportive regulatory environment, and a high demand for effective blood processing solutions. In comparison, Europe and the Asia-Pacific regions are experiencing growth, albeit at a slower rate.

Other regions showing significant growth:

Europe – Due to healthcare modernization and focus on automation in blood banks.

Asia-Pacific – Rapid growth driven by expanding healthcare infrastructure, increasing blood transfusion demand, and rising investments in medical technologies.
 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Blood Cell Washers Kits Market By Washer Type, By Modality, By End Users and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Blood Cell Washers Kits Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Blood Cell Washers Kits Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Blood Cell Washers Kits Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Blood Cell Washers Kits Market, By Washer Type Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Micro Washers
      2. Bench-top Washers
      3. Standalone Washers
  • 8.  Blood Cell Washers Kits Market, By Modality Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Manual
      2. Semi-Automated
      3. Fully Automated
  • 9.  Blood Cell Washers Kits Market, By End Users Historical Analysis and Forecast 2025-2033 (USD Million)
      1. Hospital based Laboratories
      2. Academic and Research Laboratories
      3. Others
  • 10.  North America Blood Cell Washers Kits Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2025-2033

  • 11.  Latin America Blood Cell Washers Kits Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2025-2033

  • 12.  Europe Blood Cell Washers Kits Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2025-2033

  • 13.  Asia Pacific Blood Cell Washers Kits Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2025-2033

  • 14.  Middle East and Africa Market Analysis 2018-2024 and Forecast 2025-2033 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2024
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2025-2033

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Drug Types Offered and Financial Layouts)
    •    1. Thermo Fisher Scientific
        1.1. Company Overview
        1.2. Drug Type Portfolio
        1.3. SWOT Analysis
        1.4. Financial Overview
        1.5. Strategic Overview
         2. Andreas Hettich GmbH & Co.KG
        2.1. Company Overview
        2.2. Drug Type Portfolio
        2.3. SWOT Analysis
        2.4. Financial Overview
        2.5. Strategic Overview
         3. Bio-Rad Laboratories, Inc
        3.1. Company Overview
        3.2. Drug Type Portfolio
        3.3. SWOT Analysis
        3.4. Financial Overview
        3.5. Strategic Overview
         4. Labtron
        4.1. Company Overview
        4.2. Drug Type Portfolio
        4.3. SWOT Analysis
        4.4. Financial Overview
        4.5. Strategic Overview
         5. Molecular Devices
        5.1. Company Overview
        5.2. Drug Type Portfolio
        5.3. SWOT Analysis
        5.4. Financial Overview
        5.5. Strategic Overview
         6. Biotechnology Medical Services K. Group
        6.1. Company Overview
        6.2. Drug Type Portfolio
        6.3. SWOT Analysis
        6.4. Financial Overview
        6.5. Strategic Overview
         7. Helmer Scientific
        7.1. Company Overview
        7.2. Drug Type Portfolio
        7.3. SWOT Analysis
        7.4. Financial Overview
        7.5. Strategic Overview
         8. Beckman Coulter, Inc.
        8.1. Company Overview
        8.2. Drug Type Portfolio
        8.3. SWOT Analysis
        8.4. Financial Overview
        8.5. Strategic Overview
         9. Sino Pharmaceutical Equipment Limited Co. Ltd
        9.1. Company Overview
        9.2. Drug Type Portfolio
        9.3. SWOT Analysis
        9.4. Financial Overview
        9.5. Strategic Overview
        10. Labnics Equipments ltd
        10.1. Company Overview
        10.2. Drug Type Portfolio
        10.3. SWOT Analysis
        10.4. Financial Overview
        10.5. Strategic Overview
        11. GMI Inc.
        11.1. Company Overview
        11.2. Drug Type Portfolio
        11.3. SWOT Analysis
        11.4. Financial Overview
        11.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •      

FAQ


  • Automation and integration of blood processing systems are essential for improving efficiency and accuracy in healthcare.
  • User-friendly and high-throughput cell washing systems.
  • Enhancements to Cell Therapy Workflows through Collaborative Efforts
     
  • High device costs
  • Regulatory approvals for new technologies
  • Need for trained personnel for complex equipment
     

Blood cell washer kits are medical devices designed to wash and separate blood components, including red blood cells, platelets, and plasma. They ensure the production of safe, high-quality blood products for transfusions and research purposes.

Related Market

Blood Cell Analyzer Market

Read More

Blood Cell Washers Market

Read More

Preterm Birth Diagnostic Test Kits Market

Read More
Partner

Our Clients